Novavax – Medical Alley Association

Novavax

Nucleus Network Begins Dosing for Third COVID-19 Vaccine Trial

Melbourne, Australia, Tuesday 1st September, Australia’s largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial COVID-19 Vaccine trial in collaboration with the vaccine’s developer Serum Institute of India Pvt. Ltd in partnership with the local sponsor, Accelagen Pty Ltd. 30 healthy participants, aged […]

Nucleus Network commences Novavax’ Phase 1/2 COVID-19 vaccine trial in Australia

Melbourne, Australia, Tuesday 26th May, Australia’s largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial of NVX‑CoV2373, a SARS-CoV-2 Recombinant Spike Protein Nanoparticle vaccine, at its Melbourne clinic. Nucleus Network has begun the Phase 1/2 COVID-19 vaccine trial in Australia on behalf of […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER